ArticleThe International journal on drug policy2020
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19.
Article in The International journal on drug policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19.Journal of substance abuse treatment · 2022Trial
- Navigating the COVID-19 Risk Environment, Overdose Prevention, and Self Care Practices of People Who Use Illicit Opioids in New York City.Substance use & misuse · 2025Article
- COVID-19 public health restrictions and opioid overdoes: a summative content analysis of emergency medical services records in three Texas counties.Substance abuse treatment, prevention, and policy · 2024Article
- Increases in housing rules and surveillance during COVID-19: impacts on overdose and overdose response in a community-based cohort of sex workers who use drugs in Vancouver, BC.Harm reduction journal · 2024Article
- Rapid jail-based implementation of overdose education and naloxone distribution in response to the COVID-19 pandemic.Health & justice · 2024Article
- How Ohio public library systems respond to opioid-related substance use: a descriptive analysis of survey results.BMC public health · 2024Article
- Article
- Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA.Addiction (Abingdon, England) · 2023Article
- Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model.Addiction science & clinical practice · 2023Article
- Disruptions to naloxone training among lay and occupational responders in Maryland during the emergence of COVID-19: early impacts, recovery, and lessons learned.Drug and alcohol dependence reports · 2023Article
- Article
- Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19.Substance abuse treatment, prevention, and policy · 2023Observational
- Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.BMC public health · 2023Article
- A scoping review of implementation considerations for harm reduction vending machines.Harm reduction journal · 2023Article
- The impact of the COVID-19 pandemic on access to supervised consumption programs.Substance abuse treatment, prevention, and policy · 2023Article
- SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.Harm reduction journal · 2023Article
- A rapid assessment of take-home naloxone provision during COVID-19 in Europe.The International journal on drug policy · 2022Article
- The impact of the COVID-19 lockdown on services for substance use in Denmark: Implications for meeting users' needs and recommendations for the future.Nordisk alkohol- & narkotikatidskrift : NAT · 2022Article
- The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.BMC public health · 2022Article
- Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.Drug and alcohol dependence · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.